30/10/2026
Day 1 at PODD reinforced an important point: as subcutaneous drug delivery evolves toward larger volumes and more complex formulations, manufacturing strategies must evolve alongside the device.
The conversations at the SHL Medical stand explored what these changes mean for device development, patient experience, and the infrastructure needed for commercial-scale production.
For Day 2, stop by Booth #112-113 to speak with SHL Advantec about the proven manufacturing capabilities supporting this evolution. From adaptable autoinjector assembly and final assembly to modular functional testing systems, our commercialized solutions are designed to support changing device, volume, and production requirements.
We hope to see you in Boston!